Skip Nav Destination
Issues
1 August 2014
-
Cover Image
Cover Image
Induced PDL1 expression in the tumor microenvironment can be abrogated with neutralizing antibodies against IFNγ. In the B16 model, TLR4/7/8 agonists-formulated tumor vaccine increased antitumor CTL response that correlated with increased tumor infiltrating T cells and increased PDL1 expression in the tumor microenvironment. This induction of PDL1 was found to be IFNγ dependent as shown. When combining PDL1-inducing vaccine with PD1 blocking antibody, regression of established tumors was found. For details, see article by Fu and colleagues on page 4042.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Obituary
Reviews
Perspective
Microenvironment and Immunology
Molecular and Cellular Pathobiology
Prevention and Epidemiology
Telomere Length in White Blood Cell DNA and Lung Cancer: A Pooled Analysis of Three Prospective Cohorts
Wei Jie Seow; Richard M. Cawthon; Mark P. Purdue; Wei Hu; Yu-Tang Gao; Wen-Yi Huang; Stephanie J. Weinstein; Bu-Tian Ji; Jarmo Virtamo; H. Dean Hosgood, III; Bryan A. Bassig; Xiao-Ou Shu; Qiuyin Cai; Yong-Bing Xiang; Shen Min; Wong-Ho Chow; Sonja I. Berndt; Christopher Kim; Unhee Lim; Demetrius Albanes; Neil E. Caporaso; Stephen Chanock; Wei Zheng; Nathaniel Rothman; Qing Lan
Therapeutics, Targets, and Chemical Biology
Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer
Robert T. Dauchy; Shulin Xiang; Lulu Mao; Samantha Brimer; Melissa A. Wren; Lin Yuan; Muralidharan Anbalagan; Adam Hauch; Tripp Frasch; Brian G. Rowan; David E. Blask; Steven M. Hill
Tumor and Stem Cell Biology
miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
Roberto Dinami; Cristiana Ercolani; Eleonora Petti; Silvano Piazza; Yari Ciani; Rosanna Sestito; Andrea Sacconi; Francesca Biagioni; Carlos le Sage; Reuven Agami; Roberta Benetti; Marcella Mottolese; Claudio Schneider; Giovanni Blandino; Stefan Schoeftner
An Inducible Hepatocellular Carcinoma Model for Preclinical Evaluation of Antiangiogenic Therapy in Adult Mice
Anja Runge; Junhao Hu; Matthias Wieland; Jan-Philip Bergeest; Carolin Mogler; André Neumann; Cyrill Géraud; Bernd Arnold; Karl Rohr; Dorde Komljenovic; Peter Schirmacher; Sergij Goerdt; Hellmut G. Augustin
Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
Shumei Song; Jaffer A. Ajani; Soichiro Honjo; Dipen M. Maru; Qiongrong Chen; Ailing W. Scott; Todd R. Heallen; Lianchun Xiao; Wayne L. Hofstetter; Brian Weston; Jeffrey H. Lee; Roopma Wadhwa; Kazuki Sudo; John R. Stroehlein; James F. Martin; Mien-Chie Hung; Randy L. Johnson
Correction
Advertisement